Regeneron’s COVID-19 antibody cocktail ... and has already demonstrated the benefits of dexamethasone as a treatment for COVID-19, showing the cheap steroid cut recovery times and reduced ...

Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the U.S. Food and Drug Administration has approved Dupixent for the treatment ...

Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition. The world-first study ...

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...

Legalcategory· October 4, 2024 Regeneron loses key defense in COVID-19 treatment patent lawsuit Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations ...

After failing to develop a Covid-19 vaccine, Inovio is working with AstraZeneca and the Wistar Institute on new treatment for the infectious disease. After spending years unsuccessfully attempting ...

The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License ...